Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fluorouracil sodium - solution for infusion - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fluorouracil sodium - solution for injection - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fluorouracil sodium - solution for injection - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fluorouracil sodium - solution for infusion - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - fluorouracil sodium - solution for injection - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

hospira uk ltd - fluorouracil sodium - solution for injection - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - fluorouracil sodium - solution for infusion - 50mg/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - fluorouracil sodium - solution for infusion - 50mg/1ml

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - fluorouracil - concentrate for soln for inf - 50 mg/ml

Marekani - Kiingereza - NLM (National Library of Medicine)

accord healthcare, inc. - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 50 mg in 1 ml - fluorouracil is indicated for the treatment of patients with: none. pregnancy category d risk summary there are no adequate and well-controlled studies with fluorouracil in pregnant women. based on its mechanism of action, fluorouracil can cause fetal harm when administered to a pregnant woman. administration of fluorouracil to rats and mice during selected periods of organogenesis, at doses lower than a human dose of 12 mg/kg, caused embryolethality and teratogenicity. malformations included cleft palate and skeletal defects. in monkeys, maternal doses of fluorouracil higher than an approximate human dose of 12 mg/kg resulted in abortion. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to a fetus [see clinical pharmacology (12.1)] . animal data malformations including cleft palate, skeletal defects and deformed appendages